Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years.
Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM)
Foxp3(+) Treg cells in the inflamed CNS are insensitive to IL-6-driven IL-17 production.
Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months.
Dilantin
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines.
Association of Immunotherapies With Outcomes in Relapsing-Remitting Multiple Sclerosis.
Patterns of Treatment Switching in Multiple Sclerosis Therapies in US Patients Active on Social Media: Application of Social Media Content Analysis to Health Outcomes Research.
Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.
Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
Treatment of multiple sclerosis with the pregnancy hormone estriol.
Focal vibration in neurorehabilitation.
A much-needed focus on progression in multiple sclerosis.
Once-daily AUBAGIO® delayed onset of clinically definite multiple sclerosis (MS) in TOPIC study
KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients.
Astrocyte-derived lactosylceramide implicated in multiple sclerosis.
Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis.
The brain antigen-specific B cell response correlates with glatiramer acetate responsiveness in relapsing-remitting multiple sclerosis patients.
Are natural killer cells involved in multiple sclerosis etiology? Evidences from NKp46/NCR1 receptor modulation in an observational study.
Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events.
Treatments for relapsing-remitting multiple sclerosis: summarising current information by network meta-analysis.
Prevalence of neurological disorders in Al Quseir, Egypt: methodological aspects.
A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis.
Interplay between exercise and dietary fat modulates myelinogenesis in the central nervous system.

Pages